Research output per year
Research output per year
Personal profile
External positions
European Society of Cardiology
Associate Editor, European Heart Journal: Cardiovascular Pharmacotherapy
Fingerprint
Dive into the research topics where Basil Lewis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)
ESC Scientific Document Group, 9 Feb 2024, In: European Heart Journal: Acute Cardiovascular Care. 13, 1, p. 55-161 107 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
Gibson, C. M., Duffy, D., Korjian, S., Bahit, M. C., Chi, G., Alexander, J. H., Lincoff, A. M., Heise, M., Tricoci, P., Deckelbaum, L. I., Mears, S. J., Nicolau, J. C., Lopes, R. D., Merkely, B., Lewis, B. S., Cornel, J. H., Trebacz, J., Parkhomenko, A., Libby, P. & Sacks, F. M. & 15 others, , 2 May 2024, In: New England Journal of Medicine. 390, 17, p. 1560-1571 12 p.Research output: Contribution to journal › Article › peer-review
-
Factor XIa inhibitors: collecting the clinical evidence
Lewis, B. S. & Hasegawa, K., 1 Jan 2024, In: European Heart Journal - Cardiovascular Pharmacotherapy. 10, 1, p. 5-6 2 p.Research output: Contribution to journal › Article › peer-review
Open Access -
First-in-human trial of PCSK9 gene editing therapy for lowering cholesterol: a new frontier in cardiovascular pharmacotherapy? News from AHA
Lewis, B. S., 1 Mar 2024, In: European Heart Journal - Cardiovascular Pharmacotherapy. 10, 2, p. 87-88 2 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
LIBREXIA AF Trial Investigators and Committees, Nov 2024, In: American Heart Journal. 277, p. 145-158 14 p.Research output: Contribution to journal › Article › peer-review
Open Access